Research and Markets: This Latest Report on Transdermal Drug Deliverys Technologies, Markets, and Companies is Now Available

This report deals with transdermal drug delivery – an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin … Read Full Press Release

Research and Markets: Spain Patient Monitoring and Diagnostic Systems Market Growth and Forecast To 2018: Blood Pressure Monitors, Remote Monitoring Systems and More

The Market Intelligence report provides critical market data for Spain patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It’s vital cross category comparison and … Read Full Press Release

ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer

ProNAi Therapeutics, Inc., a developer of novel nucleic acid therapeutics, announces the appointment Nick Glover, Ph.D. as President and Chief Executive Officer. The company’s previous CEO, Mina Sooch, will be leaving the organization to pursue new opportunities. On behalf of ProNAi’s board, Chairman Donald Parfet said, “The Company’s organization has reached a critical juncture. We … Read Full Press Release

Funding Patterns in the Global Pharma and Biotech Industry

– Pharma and biotech industry stock market indices have outperformed those of other industries in the study period. – Profitability is reducing in large pharmaceuticals companies. – Patent expiry and revenue loss in pharma and biotech companies. – Government efforts to contain drug prices. – Increasing market demand for drugs. – Declining research & development … Read Full Press Release

Acute Lymphocytic/Lymphoblastic Leukemia Market: 4% CAGR Forecast to 2019, Company Profiles and More

Several factors are driving global acute lymphocytic leukemia therapeutics market growth including presence of high unmet needs for appropriate drugs while current treatment options cannot cure the disease completely and hence the demand remains high. Therefore, drugs that can cause disease remission in patients are expected to drive the growth of the market. The rise … Read Full Press Release

Generex Announces Reverse Stock Split

Generex Biotechnology Corporation (OTCPink:GNBT) today announced a reverse stock split of its shares of common stock at a ratio of 1-for-1000. As of the open of the market on March 14, 2017, the Company’s common stock will begin trading on a split-adjusted basis. Generex President & Chief Executive Officer Joseph Moscato provided the following commentary … Read Full Press Release

Innovation Legislation Seeks Boost in Illinois” Bio-based Economy

Legislation designed to grow Illinois’ bio-based economy has been introduced by Senator Andy Manar (D-Bunker Hill) and Senator Chapin Rose (R-Mahomet). Senate Bill 1656 provides incentives to Illinois businesses to produce and sell new renewable products made from biomass and other renewable sources. The legislation builds upon Illinois’ strong agricultural base and seeks to provide … Read Full Press Release

Portage Provides Additional Information Relating to the Independent Director Review of the Proposed Acquisition of SalvaRx Limited

At least 660,593,556 Shares to be issued to SalvaRx Group plc. will be immediately distributed to its shareholders in the ratio of 18 consideration Portage shares for each SalvaRx share held. Following the investment in iOx, the directors evaluated several other business opportunities. After some initial due diligence, these opportunities were not pursued further. This … Read Full Press Release

Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement

Lonza is one of the world’s leading suppliers to the pharmaceutical, healthcare, and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the … Read Full Press Release

Research and Markets: Emerging Clinical Trial Locations – China: Market Dynamics and the Changing Healthcare and Regulatory Environment

Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that the current business models have become both economically unsustainable and operationally unsuited to act quickly enough to produce the … Read Full Press Release

ACD Launches RNAscope(TM) FFPE Assay Kit, a Breakthrough RNA In Situ Hybridization Product for Clinical Research and Biomarker Validation

In a blind test in collaboration with a leading pharmaceutical company, the RNAscope(TM) FFPE assay demonstrated PCR-level sensitivity and specificity, detecting an RNA biomarker in all samples deemed positive by real time RT-PCR but not in samples deemed negative. In contrast, using a traditional non-isotopic ISH, the collaborator detected the biomarker only in the highest … Read Full Press Release

Vista Partners Initiates Coverage on Targeted Medical Pharma – Video Research Alert on InvestmentPitch.com

The company reported total revenue of $6.9 million for the nine months ending September 30, 2013, an increase of 41% over the nine months ended September 30, 2012. The company is a Los Angeles-based biotechnology company that develops and commercializes nutrient-based and pharmaceutical therapeutic systems. Its patented prescription medical food products for the treatment of … Read Full Press Release

/C O R R E C T I O N from Source — Oncolytics Biotech Inc./

The primary objectives of the trial are to estimate the progression-free survival hazard ratio of the combination of weekly paclitaxel with REOLYSIN to weekly paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer and to determine the frequency and severity of adverse events associated with treatment with weekly paclitaxel … Read Full Press Release

Human Preclinical Study Significant Milestone; PharmaCyte Biotech Analyst Brief Issued by BrokerBank Securities, Inc.

PMCB has achieved developmental progress over the past year and the launch of a series of clinical trials in 2015 should raise the company’s profile. These milestones include mid-stage and preclinical studies for the treatment of pancreatic cancer and its serious and debilitating symptoms, and for diabetes. An analyst brief which covers a brief analysis … Read Full Press Release

Biotechnology Stocks Under Review – Eleven Biotherapeutics, Relypsa, Galena Biopharma, and Amgen

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on … Read Full Press Release

Alzheon Appoints Neil Flanzraich, JD, as Chief Business Officer

Neil Flanzraich, JD, Chief Business Officer, Alzheon, Inc. (Photo: Business Wire) “I am delighted to welcome such an accomplished executive as Neil to the Alzheon team,” said Martin Tolar, MD, PhD, Founder, President and Chief Executive Officer of Alzheon. “Neil is an entrepreneur and investor with an exceptional track record driving business and financing strategies, … Read Full Press Release